Downloadable medical computer software platforms containing diagnostic algorithms and decision-making computation to support screening, diagnosing, monitoring and treatment modalities of diseases; downloadable medical computer software platforms for aiding in decision-making in clinical and after-regulatory approval of therapeutics and diagnostics; downloadable medical computer software platforms for managing and maintaining pre-clinical trials, clinical trials and assessments of patient's tumors in their staging and treatment; Pharmaceutical preparations for the treatment of cancer featuring small molecules, biopharmaceuticals, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics; Pharmaceutical preparations for the treatment of cancer for use in cellular therapies, gene therapies, N - 1 personalized drug therapies, and CAR T-cell therapy; Pharmaceutical preparations for the treatment of cancer derived from CRISPR-Cas9 and CAR T-Cell; Vaccine preparations; Antibodies for medical purposes, namely, monoclonal antibodies and bi-specific antibodies; Medical diagnostic reagents and diagnostic preparations for use in-vitro, in-vivo, cell-based assays, cell culture processes, laboratory-developed tests (LDTs), cell-based imagining, genomics, gene-based expression assays, proteomics, protein-based expression assays, immunohistochemistry (IHC), drug sensitivity and treatment diagnostics; Biobanking services, namely, human and animal organ and tissue bank services; Medical digital pathology services for diagnostic or treatment purposes of human and animal tumors; Medical imaging services for cellular systems for the characterization of human and animal tumors; Medical apparatus for personalized medical therapeutics, namely, infusion and injection devices for administering therapeutic drugs of various types, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics, into the human body utilizing both in-vivo and in-vitro, gene or cellular therapy methods; Medical research services in personalized medicine, patient treatment, therapeutics and diagnostics
